Name
Täisühing Aravete Apteek
Registry code
10000127
VAT number
EE100660544
Type
TÜ - General Partnership
Status
Registered
Foundation date
27.09.1995 (29)
Financial year
01.01-31.12
Activity
47731 - Dispensing chemist in specialised stores
799 932 €
24 959 €
3%
2 283 €
(estimate is approximate)
62 465 €
2
Submitted
No tax arrears
40%
12%
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Lea Kruusimägi 04.11.1953 (70) | - | Full partner | Direct ownership | |
| Milvi Petenberg 14.06.1963 (61) | - | Full partner | - |
| 2019 04.06.2020 | 2020 23.04.2021 | 2021 17.05.2022 | 2022 01.06.2023 | 2023 20.05.2024 | |
|---|---|---|---|---|---|
| Total Revenue | 482 504 € | 558 617 € | 620 024 € | 763 419 € | 799 932 € |
| Net profit (loss) for the period | 24 145 € | 14 483 € | 11 104 € | 29 969 € | 24 959 € |
| Profit Margin | 5% | 3% | 2% | 4% | 3% |
| Current Assets | 134 064 € | 156 336 € | 172 845 € | 195 226 € | 200 047 € |
| Fixed Assets | 1 173 € | 1 253 € | 708 € | 227 € | 67 € |
| Total Assets | 135 237 € | 157 589 € | 173 553 € | 195 453 € | 200 114 € |
| Current Liabilities | 74 986 € | 106 209 € | 127 325 € | 132 158 € | 137 649 € |
| Non Current Liabilities | - | - | - | - | - |
| Total Liabilities | - | - | - | - | - |
| Share Capital | - | - | - | - | - |
| Equity | 60 251 € | 51 380 € | 46 228 € | 63 295 € | 62 465 € |
| Employees | 2 | 2 | 2 | 2 | 2 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q1 | 189 984.09 € | 12 068.16 € | 6 441.71 € | 2 |
| 2023 Q4 | 225 347.54 € | 11 350.12 € | 7 303.76 € | 2 |
| 2023 Q3 | 183 380.92 € | 10 601.84 € | 7 390.23 € | 2 |
| 2023 Q2 | 201 201.18 € | 10 418.68 € | 7 071.83 € | 2 |
| 2023 Q1 | 192 910.69 € | 11 155.57 € | 6 599.22 € | 2 |
| 2022 Q4 | 195 522.1 € | 9 915.74 € | 6 600.06 € | 2 |
| 2022 Q3 | 186 040.15 € | 11 003.12 € | 7 418.2 € | 2 |
| 2022 Q2 | 198 677.18 € | 9 248.14 € | 6 636.85 € | 2 |
| 2022 Q1 | 166 510.91 € | 10 355.57 € | 6 753.32 € | 2 |
| 2021 Q4 | 176 072.71 € | 8 110.34 € | 5 050.3 € | 2 |
| 2021 Q3 | 158 316.9 € | 7 137.62 € | 5 784 € | 2 |
| 2021 Q2 | 147 296.8 € | 8 364.47 € | 5 564.01 € | 2 |
| 2021 Q1 | 140 363.77 € | 6 589.82 € | 6 278.55 € | 2 |
| 2020 Q4 | 141 491.22 € | 7 510.64 € | 5 336.23 € | 2 |
| 2020 Q3 | 125 014.7 € | 7 405.38 € | 4 928.13 € | 2 |
| 2020 Q2 | 157 214.76 € | 6 549.83 € | 4 213.93 € | 2 |
| 2020 Q1 | 116 415.2 € | 8 717.01 € | 4 503.35 € | 2 |
